Dupuytren Contracture Global Clinical Trials Review, H2, 2017

Price :
Published : Jul-2017
No. of Pages : 61

Dupuytren Contracture Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Dupuytren Contracture Global Clinical Trials Review, H2, 2017” provides an overview of Dupuytren Contracture clinical trials scenario. This report provides top line data relating to the clinical trials on Dupuytren Contracture. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Amedisys Inc (AMED) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Amedisys Inc (Amedisys) is a healthcare company that offers home health care, hospice service and personal care. The company provides practical nursing services and occupational therapy, comfort and support services for those are facing a terminal illness. It also provides speech pathology, social services for acute and chronic illnesses, private duty services and home health aide services. The company operates a network of medicare-certified home health care centers, and medicare-certified hospice care centers which cover across several states in the US and the District of Columbia. Amedisys is headquartered in Baton Rouge, Louisiana, the US. Amedisys Inc (AMED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the......

Bayer AG (BAYN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women's healthcare, oncology, hematology, ophthalmology, infection and other indications. The company's product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter - OTC) products, seeds, crop protection solutions, nonagricultural pest control solutions, and high-tech polymer materials. Bayer markets its healthcare and crop protection products principally through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacifi......

Alnylam Pharmaceuticals Inc (ALNY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiovascular and metabolic disease; and hepatic infectious disease. It also offers Alnylam 5x15 program for advancing genetically defined disease targets for the treatment of respiratory syncytial virus and liver cancer. Alnylam employs lipid nanoparticles for intravenous systemic delivery of sRNAi to right body organs and cells so that it could trigger the RNAi mechanism. The company works in partnership with Merck, Medtronic, Roche, Novartis, Biogen, Takeda, Cubist, GlaxoSmithKline, Ascletis, The M......

Bristol-Myers Squibb Co (BMY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic classes. The company offers its products across the world primarily to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company's research activities focus on the discovery and development of novel medicines that address serious disease in areas of significant unmet medical need. BMS is headquartered in N......

Pfizer Inc (PFE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, immune disorders and rare diseases, besides vaccines. It also provides sterile injectable pharmaceuticals, infusion systems, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells prescription medicines through wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company provides its products in ......

Rockwell Medical Inc (RMTI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major products include hemodialysis concentrates, dialysis kits and ancillary products used in the dialysis process. The company's products find applications in the treatment of iron deficiency and secondary hyperparathyroidism; and for hemodialysis. The company markets its products through distributors in the US and through independent sales agents, direct sales force and distributors in overseas markets. RockWell has operations in the US, Latin America, Asia and Europe. Rockwell is headquartered in Wixom,......

Kolon Life Science Inc (102940) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kolon Life Science Inc (KLS) carries out research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, first cell-mediated gene therapy for osteoarthritis. KLS' product portfolio includes biopharmaceuticals, APIs, antimicrobials and water treatment solutions. Its technology platform produces and utilizes protein for human body by performing gene manipulation and cell culturing technology. The company's cell-mediated gene therapies are used in degenerative diseases. It offers anti-bacterial agents for cosmetic, paint and other industries and water treatment agents. KLS is headquartered in Gwachun-si, Gyunggi-do, South Korea......

Roche Diagnostics International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland. Roc......

AMAG Pharmaceuticals Inc (AMAG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth in women, Feraheme (ferumoxytol) for iron deficiency anemia in adult patients with chronic kidney disease and MuGard Oral Mucoadhesive for the management of oral mucositis and all types of oral wounds including aphthous ulcers/canker sores and traumatic ulcers. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers these products through direct sales and a netwo......

Veloxis Pharmaceuticals AS (VELO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company, which develops therapies for kidney transplantation based on its proprietary MeltDose platform. MeltDose is a drug delivery technology, used to enhance oral bioavailability and control release of a drug. The company's product portfolio consists of Envarsus XR, anti-rejection drug for patients who had kidney transplantation; and Fenoglide for the treatment of dyslipidemia. The company out licensed the commercial rights of Fenoglide for the US, Canada and Mexico; and Envarsus to Chiesi in Europe, Turkey and CIS countries. It has a wholly owned subsidiary, Veloxis Pharmaceuticals Inc., in New Jersey, the US. Veloxis is headquartered in Copenhagen, Denmark. Veloxis Pharmaceuticals AS (VELO) - Pharmaceuticals......